Comparison of surgery and surgery plus corticosteroid therapy in idiopathic granulomatous mastitis, prospective randomized study

2019 ◽  
Vol 26 (12) ◽  
pp. 2984
Author(s):  
Mehmet Patmano ◽  
Alper Akcan ◽  
Abdullah Oz ◽  
Turkmen Arikan ◽  
Serap Dogan ◽  
...  
2019 ◽  
Vol 43 (11) ◽  
pp. 2865-2873 ◽  
Author(s):  
Kenan Çetin ◽  
Hasan E. Sıkar ◽  
Nuri E. Göret ◽  
Günay Rona ◽  
Nagehan Ö. Barışık ◽  
...  

2021 ◽  
Vol 107 (1_suppl) ◽  
pp. 13-13
Author(s):  
R Amira Maher ◽  
Ahmed Gamal Eldin Osman ◽  
K Fahmy ◽  
Shinamwi M ◽  
Osama Al Atarash

Introduction: Idiopathic granulomatous mastitis is a rare benign breast disease. Initial reports from hospitals in Egypt from Departments of Pathology at Cancer Institutes of Cairo, Tanta and Mansoura Universities; indicate that the disease is not as rare as that in the developed countries. It often mimics breast carcinoma both clinically and radiologically. Histological examination is the gold standard for diagnosis. Management of Idiopathic granulomatous mastitis is still debatable. In our study, we aimed to evaluate the addition of corticosteroid therapy to surgical excision in management of idiopathic granulomatous mastitis. Patients and Methods: This is a comparative study was conducted at Ain-Shams University Hospital’s breast clinic on patients with idiopathic granulomatous mastitis from to August 2015 till September 2018. Thirty patients were divided into 2 groups. Group (A) includes patients who underwent surgical management only. Group (B) includes patients who received corticosteroid therapy according to the severity of the cases then surgical Excision was done for the residual lesion. Follow up of all cases up to 1-2 years was done to document the recurrence rate and compare the cosmetic outcome of both groups. Informed consent was obtained from all patients included in the study. Results: The mean age of the affected women was 38.80 and 33.13 in group (A) and group (B), respectively and it wasn’t statistically different (p value = 0.099). The most common presenting symptom was a palpable mass in the breast (66.7% and 93.3%) in group (A) and group (B) respectively. Recurrence rate was higher in group (A) (40%) with no recurrence documented in group (B) however 2 cases were omitted from the study due to steroid noncompliance and complications. Cosmetic outcome was excellent in 76.9% of group (B) and good in 53.3% of group (A). Conclusion: Systemic steroid therapy with surgical resection is the recommended as first-line treatment strategy for IGM as it shows less recurrence rate and surgical scarring. Increased awareness of IGM will increase their understanding and improve their management.


Surgery Today ◽  
2011 ◽  
Vol 41 (3) ◽  
pp. 333-337 ◽  
Author(s):  
Kenichi Sakurai ◽  
Shigeru Fujisaki ◽  
Katsuhisa Enomoto ◽  
Sadao Amano ◽  
Masahiko Sugitani

Breast Care ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. 111-115 ◽  
Author(s):  
Alper Akcan ◽  
A. Bahadir Öz ◽  
Serap Dogan ◽  
Hülya Akgün ◽  
Muhammet Akyüz ◽  
...  

2007 ◽  
Vol 177 (4S) ◽  
pp. 453-453 ◽  
Author(s):  
Ervin Kocjancic ◽  
Simone Crivellaro ◽  
Fabio Bernasconi ◽  
Fabio Magatti ◽  
Bruno Frea ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 142-142 ◽  
Author(s):  
Antonella Giannantoni ◽  
Savino M. Di Stasi ◽  
Robert L. Stephen ◽  
Gerardo Pizzirusso ◽  
Ettore Mearini ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document